Biofrontera Inc
BFRIW0.150USD
+0.020+15.03%
Market hours （ET）Quotes delayed by 15 min
0.00Market Cap
--P/E TTM
More Details of Biofrontera Inc Company
Biofrontera Inc. is a biopharmaceutical company. The Company is focused on commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. The Company's licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. Its principal licensed product is Ameluz, which is a prescription drug for use in combination with the BF-RhodoLED lamp series, for photodynamic therapy. In the United States, the PDT treatment is used for the lesion-directed and field-directed treatment of actinic keratoses (AK) of mild-to-moderate severity on the face and scalp. Its second prescription drug licensed product in its portfolio is Xepi, which is a topical non-fluorinated quinolone that inhibits bacterial growth and used for the treatment of impetigo due to Staphylococcus aureus or Streptococcus pyogenes.
Company Info
Ticker SymbolBFRIW
Company nameBiofrontera Inc
IPO dateOct 14, 2021
CEOProf. Dr. Hermann Luebbert, Ph.D.
Number of employees- -
Security typeCompany Warrant
Fiscal year-end- -
Address120 Presidential Way,
CityWOBURN
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code01801
Phone17812451325
Websitehttps://www.biofrontera-us.com/
Ticker SymbolBFRIW
IPO dateOct 14, 2021
CEOProf. Dr. Hermann Luebbert, Ph.D.
Company Executives
Name
Name/Position
Position
Shareholding
Change
Dr. Beth J. Hoffman, Ph.D.
Dr. Beth J. Hoffman, Ph.D.
Independent Director
Independent Director
--
--
Prof. Dr. Hermann Luebbert, Ph.D.
Prof. Dr. Hermann Luebbert, Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Mr. Eugene Frederick (Fred) Leffler, III
Mr. Eugene Frederick (Fred) Leffler, III
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Heikki Lanckriet, Ph.D.
Dr. Heikki Lanckriet, Ph.D.
Director
Director
--
--
Dr. John J. Borer, III
Dr. John J. Borer, III
Independent Director
Independent Director
--
--
Mr. Kevin D. Weber
Mr. Kevin D. Weber
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Dr. Beth J. Hoffman, Ph.D.
Dr. Beth J. Hoffman, Ph.D.
Independent Director
Independent Director
--
--
Prof. Dr. Hermann Luebbert, Ph.D.
Prof. Dr. Hermann Luebbert, Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Mr. Eugene Frederick (Fred) Leffler, III
Mr. Eugene Frederick (Fred) Leffler, III
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Heikki Lanckriet, Ph.D.
Dr. Heikki Lanckriet, Ph.D.
Director
Director
--
--
Dr. John J. Borer, III
Dr. John J. Borer, III
Independent Director
Independent Director
--
--
Mr. Kevin D. Weber
Mr. Kevin D. Weber
Independent Director
Independent Director
--
--
Revenue Breakdown
No Data
No Data
By Business
By Region
No Data
Shareholding Stats
Updated: Sun, May 18
Updated: Sun, May 18
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Other
100.00%
Shareholders
Shareholders
Proportion
Other
100.00%
Shareholder Types
Shareholders
Proportion
Other
100.00%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
9
202.57K
0.00%
-20.78K
2025Q1
9
202.57K
0.00%
-20.78K
2024Q4
8
194.67K
0.00%
-33.12K
2024Q3
8
199.21K
0.00%
-22.07K
2024Q2
10
279.32K
0.00%
-36.16K
2024Q1
10
301.92K
0.00%
-5.11K
2023Q4
9
293.58K
0.00%
-20.78K
2023Q3
10
302.16K
0.00%
-106.34K
2023Q2
9
396.31K
0.00%
-26.09K
2023Q1
9
410.19K
0.00%
+88.68K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Two Sigma Investments, LP
10.24K
0%
+10.24K
--
Mar 31, 2025
Bard Associates Inc.
179.90K
0%
--
--
Mar 31, 2025
Clear Street LLC
9.44K
0%
-705.00
-6.95%
Mar 31, 2025
UBS Financial Services, Inc.
891.00
0%
-1.63K
-64.63%
Mar 31, 2025
Osaic Holdings, Inc.
1.10K
0%
--
--
Mar 31, 2025
U.S. Bancorp Asset Management, Inc.
1.00K
0%
--
--
Mar 31, 2025
Susquehanna International Group, LLP
--
0%
-16.96K
-100.00%
Jun 30, 2024
Citadel Advisors LLC
--
0%
-11.62K
-100.00%
Sep 30, 2024
BofA Global Research (US)
--
0%
-100.00
-100.00%
Dec 31, 2024
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
